SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001558370-24-008542
Filing Date
2024-05-21
Accepted
2024-05-21 17:14:58
Documents
16
Period of Report
2024-05-08
Items
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K/A chrs-20240508x8ka.htm   iXBRL 8-K/A 42496
2 EX-10.1 chrs-20240508xex10d1.htm EX-10.1 1019172
3 EX-10.2 chrs-20240508xex10d2.htm EX-10.2 481218
  Complete submission text file 0001558370-24-008542.txt   1930042

Data Files

Seq Description Document Type Size
4 EX-101.SCH chrs-20240508.xsd EX-101.SCH 4157
5 EX-101.DEF chrs-20240508_def.xml EX-101.DEF 3158
6 EX-101.LAB chrs-20240508_lab.xml EX-101.LAB 15907
7 EX-101.PRE chrs-20240508_pre.xml EX-101.PRE 10735
19 EXTRACTED XBRL INSTANCE DOCUMENT chrs-20240508x8ka_htm.xml XML 4857
Mailing Address C/O DENNIS M. LANFEAR 333 TWIN DOLPHIN DR, SUITE 600 REDWOOD CITY CA 94065
Business Address C/O DENNIS M. LANFEAR 333 TWIN DOLPHIN DR, SUITE 600 REDWOOD CITY CA 94065 (650) 649-3530
Coherus BioSciences, Inc. (Filer) CIK: 0001512762 (see all company filings)

IRS No.: 273615821 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-36721 | Film No.: 24970643
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)